Avnet Increases Share Buyback Plan to $600 Million-February 2024-www.financetom.com

Avnet Increases Share Buyback Plan to $600 Million

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Avnet Increases Share Buyback Plan to $600 Million

Aug 19, 2024 5:53 AM

08:38 AM EDT, 08/19/2024 (MT Newswires) -- Avnet (AVT) said Monday its board increased its share buyback plan to $600 million.

The company also raised its regular quarterly cash dividend 6% to $0.33 per share, payable Sept. 25 to shareholders of record as of Sept. 11.

Price: 54.82, Change: +0.60, Percent Change: +1.11

Previous page： NextTrip Provides Shareholder Update Following Completion of TA Pipeline Acquisition Next page： InMode Q3 Non-GAAP Earnings, Revenue Fall; Reiterates 2025 Guidance

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

NextTrip Provides Shareholder Update Following Completion of TA Pipeline Acquisition

Nov 5, 2025

Announces Launch of New TA Pipeline Website and Expanding Market Interest Surge in Partnership Discussions, Supplier Inquiries and Agency Sign-Ups Following Recent Cancún Travel Mart Event SANTA FE, NEW MEXICO / ACCESS Newswire ( ACCS ) / November 5, 2025 / NextTrip, Inc. ( NTRP ) , a technology-forward media and travel company redefining how people discover, plan, and book...

InMode Q3 Non-GAAP Earnings, Revenue Fall; Reiterates 2025 Guidance

Nov 5, 2025

09:02 AM EST, 11/05/2025 (MT Newswires) -- InMode ( INMD ) reported Q3 non-GAAP earnings Wednesday of $0.38 per diluted share, down from $0.70 a year earlier. Analysts polled by FactSet expected $0.35. Revenue for the quarter ended Sept. 30 was $93.2 million, compared with $130.2 million a year earlier. Analysts surveyed by FactSet expected $90.5 million. For 2025, the...

Appili Therapeutics Announces $750,000 Private Placement for Working Capital, Drug Development

Nov 5, 2025

09:01 AM EST, 11/05/2025 (MT Newswires) -- Appili Therapeutics ( APLIF ) , a biopharmaceutical company focused on drug development for infectious diseases and biodefense, announced Wednesday a non-brokered private placement for about $750,000. The company said the offering will be comprised of the issuance of up to about 30-million units at $0.025 apiece. Each unit will consist of one...

BRIEF-TIAN RUIXIANG Holdings Enters Into Agreement to Acquire REN Talents

Nov 5, 2025

Nov 5 (Reuters) - Tian Ruixiang Holdings Ltd ( TIRX ): * TIAN RUIXIANG HOLDINGS LTD. ( TIRX ) ENTERS INTO AGREEMENT TO ACQUIRE REN TALENTS INC. * TIAN RUIXIANG HOLDINGS LTD ( TIRX ): WILL ISSUE 3.2 MILLION CLASS A ORDINARY SHARES AT A PRICE OF $2.18 PER SHARE FOR DEAL Source text: Further company coverage: ...